Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies

Clinical Studies ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Meta Analyses

Subpopulation Differences in the Cardiovascular Efficacy of Long-Acting Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis

Diabetes Therapy ◽

10.1007/s13300-020-00882-2 ◽

2020 ◽

Vol 11 (9) ◽

pp. 2121-2143

Author(s):

Liyun He ◽

Na Yang ◽

Lingling Xu ◽

Fan Ping ◽

Wei Li ◽

...

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Long Acting

Clinical Studies of Liraglutide, a Novel, Once-Daily Human Glucagon-Like Peptide-1 Analog for Improved Management of Type 2 Diabetes Mellitus

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ◽

10.1592/phco.29.pt2.43s ◽

2009 ◽

Vol 29 (12, part 2) ◽

pp. 43S-54S ◽

Cited By ~ 12

Author(s):

Scott R Drab

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Clinical Studies ◽

Once Daily ◽

Glucagon Like Peptide ◽

Glucagon-like peptide-1 receptor agonists versus insulin glargine for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials

Current Therapeutic Research ◽

10.1016/j.curtheres.2010.08.003 ◽

2010 ◽

Vol 71 (4) ◽

pp. 211-238 ◽

Cited By ~ 20

Author(s):

Wei-Xin Li ◽

Jian-Feng Gou ◽

Jin-Hui Tian ◽

Xiang Yan ◽

Lin Yang

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Tumour Risk with Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus Patients: A Systematic Review

Clinical Drug Investigation ◽

10.1007/s40261-016-0389-8 ◽

2016 ◽

Vol 36 (6) ◽

pp. 433-441 ◽

Cited By ~ 9

Author(s):

Xia Guo ◽

Qing Yang ◽

Jianjun Dong ◽

Lin Liao ◽

Weiwei Zhang ◽

...

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

The effects of dipeptidyl peptidase-4 inhibitors and glucagon-like peptide 1 receptor agonists on cognitive functions in adults with type 2 diabetes mellitus: a systematic review and meta-analysis

Acta Diabetologica ◽

10.1007/s00592-020-01529-1 ◽

2020 ◽

Vol 57 (10) ◽

pp. 1129-1144

Author(s):

Yuxin Jin ◽

Hang Zhao ◽

Yilin Hou ◽

Guangyao Song

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Dipeptidyl Peptidase 4 ◽

Dipeptidyl Peptidase 4 Inhibitors ◽

Glucagon Like Peptide ◽

Glucagon-like peptide-1 receptor agonists compared with basal insulins for the treatment of type 2 diabetes mellitus: a systematic review and meta-analysis

Diabetes Obesity and Metabolism ◽

10.1111/dom.12805 ◽

2016 ◽

Vol 19 (2) ◽

pp. 228-238 ◽

Cited By ~ 33

Author(s):

Sonal Singh ◽

Eugene E. Wright ◽

Anita Y. M. Kwan ◽

Juliette C. Thompson ◽

Iqra A. Syed ◽

...

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Cardioprotective properties of glucagon-like peptide-1 receptor agonists in type 2 diabetes mellitus patients: A systematic review

Diabetes & Metabolic Syndrome Clinical Research & Reviews ◽

10.1016/j.dsx.2021.04.005 ◽

2021 ◽

Vol 15 (3) ◽

pp. 837-843

Author(s):

Wynne Widiarti ◽

Alverina Cynthia Sukmajaya ◽

David Nugraha ◽

Firas Farisi Alkaff

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Receptor Agonists ◽

Glucagon Like Peptide ◽

Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) plus Basal Insulin vs. GLP-1RA in Type 2 Diabetes Mellitus—A Systematic Review and Meta-analysis

Diabetes ◽

10.2337/db18-1108-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 1108-P

Author(s):

MUNIZA M. SATTI ◽

TIMOTHY O'BRIEN ◽

AARON LIEW

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Receptor Agonist ◽

Meta Analysis ◽

Efficacy And Safety ◽

Glucagon Like Peptide ◽

Efficacy and Safety of Long-Acting Glucagon-Like Peptide-1 Receptor Agonists Compared with Exenatide Twice Daily and Sitagliptin in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis

Annals of Pharmacotherapy ◽

10.1345/aph.1q024 ◽

2011 ◽

Vol 45 (7-8) ◽

pp. 850-860 ◽

Cited By ~ 41

Author(s):

Nicole R Pinelli ◽

Kathryn M Hurren

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Meta Analysis ◽

Efficacy And Safety ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Long Acting

Combination of Premixed Insulin with Glucagon-Like Peptide-1 Receptor Agonist (GLP-1) for Uncontrolled Type 2 Diabetes Mellitus (T2DM) Patients

Diabetes ◽

10.2337/db18-2231-pub ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 2231-PUB

Author(s):

SASAN FAZELI ◽

NICOLE EHRHARDT

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Receptor Agonist ◽

Premixed Insulin ◽

Glucagon Like Peptide ◽